Do you have a Nexplanon® implant?

The purpose of this clinical trial is to learn about using the etonogestrel implant for more than 3 years.

You may be able to join if you:

• Have an etonogestrel implant that was inserted 34–36 months ago (about 3 years ago)
• Are willing to continue to use the etonogestrel implant for an additional 24 months and do not intend to use any other form of contraception (for example, condoms)
• Are between 18 and 35 years old

There may be reasons why you cannot be in this clinical trial. The trial doctor or staff will discuss these with you.

If you join, you will:

• Be in the trial for about 27 months
• Visit the trial site 11 times for the trial doctor and staff to check on your health and collect information for research purposes

Being part of this clinical trial is voluntary and you may choose to leave the trial for any reason at any time.

For more information, including possible risks and benefits of participation, or if you want to take part in this clinical trial, please contact us today. 

You will be compensated for your time and travel if you qualify

Who can be in this study?

• Boys and girls 9-11 years of age who have:
• No previous diagnosis of Covid-19
• Not yet received an HPV vaccine such as Gardasil 9
• Not yet received a COVID-19 vaccine
• A parent or legal guardian who:
• Will attend all study visits
• Agrees that the study doctor or staff may be in contact during the study
• Additional requirements apply, which the study doctor can discuss with you.

What vaccines will participants get as part of this study?

Everyone in this study will get:

A 2-dose regimen of the Moderna COVID-19 vaccine 

A 2-dose regimen of the HPV vaccine Gardasil 9

You will be compensated for your time and travel if you qualify

About the LUMINOUS Study

This clinical research study is investigating whether an investigational contraceptive skin patch can prevent pregnancy in women, and how well tolerated it is.

This study is for you if you:

• are sexually active 
• are at least 16 years of age  (and legally permitted to use contraceptives)
• have normal, regular menstrual cycles
• wish to prevent and have no plans for pregnancy for at least 12 months
• are willing to try an investigational hormonal method of birth control
• are willing to use the study patch as your only method of birth control for at least 12 months.

If you have answered yes to all of the above then you may be able to take part in the LUMINOUS Study. There are other criteria that you will need to meet to qualify, which the study team can discuss with you.

All participants will receive the investigational contraceptive patch there is no 'dummy or placebo patch in this study.

You will be compensated for your time and travel if you qualify

What will this study involve?

This study is for you if you:

• are 35 years of age or younger at onset of study participation
• are having vaginal sexual intercourse with a male partner at least once a month
• do not wish to become pregnant within the next year
• have a history of regular menstrual cycles of 21 to 35 days prior to the use of any hormonal contraceptive.

These are some of the things you will need to do:

Daily diary entries

Take the investigational medication, once a day, by mouth.

If you take part, you will be in the OG-8175A-023 Study for up to 14 months.

You will be compensated for your time and travel if you qualify

CLINICAL TRIAL FOR ACTIVE UTI IN WEST PALM BEACH, FL

• Female participants only who are aged 18+ experiencing active UTI symptoms. 
• Symptoms of a urinary tract infection include painful urination, frequent urination, urgency to urinate, and lower abdominal pain.
• No oral antibiotics or antifungal medications taken in the last week

Four study visits within a 30-day period. 

You will be compensated for your time and travel if you qualify

COVID-19 RESEARCH STUDY IN WEST PALM BEACH, FL

Eligibility Criteria for COVID-19 Research Study

For this study, we are seeking individuals in and around West Palm Beach who are experiencing symptoms or have been exposed to COVID-19. As defined by the CDC, the most common out of a wide range of symptoms include:

• Fever or chills
• Cough
• Shortness of breath or difficulty breathing
• Fatigue
• Muscle or body aches
• Headache
• New loss of taste or smell
• Sore throat
• Congestion or runny nose
• Nausea or vomiting
• Diarrhea

In addition to being symptomatic, the only other criteria to participate in this research study is that you must be 18 or older and willing to have one or multiple nasal swabs. 

If you qualify and choose to participate, you will be helping us get one step closer to achieving broader, faster COVID-19 testing that also more accurately identifies variant strains.

If you believe you are eligible for the COVID-19 research study at Comprehensive Clinical Research in West Palm Beach, FL, give us a call at 561-478-3177 today to answer our prescreening questions and get enrolled!

You will be compensated for your time and travel if you qualify

This study is for you if you:

A Female 

Are between the ages 18-45 with regular menstrual cycles

No osteopenia or osteoporosis 

These are some of the things you will need to do:

4 in-person visits over 12 months

You will be compensated for your time and travel if you qualify

A Phase IV, Longitudinal, Observational Study Examining
Real-World Outcomes of Non-Hormonal Pharmacotherapies
among Individuals Treated for Bothersome Vasomotor

What will this study involve?

Participants will be in the study for 2 years following the first visit. You will start a new course of treatment with a non-hormonal medication for the treatment of Hot Flashes. The study will assess the change in symptom bother from the first visit of participants initiating non hormonal medicine for the treatment of VMS in the real-world setting. The study will also assess impact on sleep characteristics/quality, treatment satisfaction, impact on quality of life (including mood and sexual health), work productivity.

This study is for you if you:

• You were assigned female at birth aged 40 through 75 years.
• You were diagnosed with bothersome VMS due to/associated with menopause for at least 3 months.
• You are utilizing complementary and alternative therapies, mind-body techniques, or supplements for the treatment of VMS: participant has been on such therapies for ≥ 3 months and intends to continue through duration of study.

These are some of the things you will need to do:

Diary Entries 

Study Visits for 24 weeks

Take medication as instructed

You will be compensated for your time and travel if you qualify.

What will this study involve?

Participants will be in the study for 1 year following the first visit. You will start a new course of treatment with a non-hormonal medication for the treatment of Hot Flashes. The study will assess the change in symptom bother from the first visit of participants initiating non hormonal medicine for the treatment of VMS in the real-world setting. The study will also assess impact on sleep characteristics/quality, treatment satisfaction, impact on quality of life (including mood and sexual health), work productivity.

This study is for you if you:

• are Female 40-65 with vasomotor menopausal symptoms.
• FSAD was diagnosed by an expert and in accordance with DSM-IV-TR
• are Postmenopausal status or have had a hysterectomy greater then 6 months ago.
• have sexual activity at least two times each month during the last 6 months and agrees to have sexual activity at least two times each month for the duration of the study. Sexual activity can include any activity that may result in sexual stimulation or sexual pleasure e.g., intercourse, caressing, foreplay, masturbation, and oral sex.

These are some of the things you will need to do:

Daily diary entries.

Take the investigational medication.

If you take part, you will be in the Study for up to 4 months.

You will be compensated for your time and travel if you qualify.

A Phase 3B, Single-Arm, Open-Label Study to Evaluate Bone Mineral Density
with Long-Term Use of Relugolix Combination Tablet in Premenopausal Women with Heavy Menstrual Bleeding Associated with Uterine Fibroids or Moderate to Severe Pain Associated with Endometriosis

What will this study involve?

The primary objective of this study is to characterize changes in bone mineral density.

This study is for you if you:

• Are a premenopausal woman, 18 to 50 years of age (inclusive).
• Has either of the following conditions:
  a. A diagnosis of uterine fibroids confirmed by imaging or review of medical records and reports heavy menstrual bleeding negatively affecting quality of life. b. A diagnosis of endometriosis
• If at risk of pregnancy is willing to avoid pregnancy for 4 years (the duration of the treatment period) using nonhormonal methods of contraception;

These are some of the things you will need to do:

Study Visits and phone calls

Take the investigational medication.

If you take part, you will be in the Study for up to 4 years.

You will be compensated for your time and travel if you qualify.